Nighttime SBP variability (SD) from ABPM independently predicts subclinical TOD and guides organ protection in hypertension and subclinical TOD prediction in hypertension is confirmed.
Abstract
Background Short-term blood pressure variability (BPV) from 24-h ambulatory blood pressure monitoring (ABPM) lacks evidence for predicting subclinical target organ damage (TOD). Objective The study assessed BPV from ABPM for subclinical TOD prediction in hypertension. Methods This retrospective study screened 180 essential hypertension patients at Quanzhou First Hospital between January 2023 and December 2025, and 176 patients were enrolled after exclusion. All participants underwent standardized 24-h ABPM examination. Several short-term BPV parameters were calculated, including standard deviation (SD), coefficient of variation (CV), and average real variability (ARV) for systolic blood pressure (SBP) and diastolic blood pressure (DBP) across 24-h, daytime, and nighttime periods. Patients were allocated into a TOD group and a non-TOD group based on the presence or absence of subclinical TOD. Multivariate logistic regression was used to assess BPV indices as independent predictors of subclinical TOD. Receiver operating characteristic (ROC) curve analysis assessed the predictive performance of these indices with the area under the curve (AUC) calculated. Results Among 176 patients, 94 were assigned to the TOD group and 82 to the non-TOD group, with balanced baseline characteristics (all P > 0.05). The TOD group showed significantly higher 24-h, daytime, and nighttime BP SD, CV, and ARV (all P < 0.001). Multivariate logistic regression identified nighttime SBP SD, 24-h SBP ARV, and nighttime SBP ARV as independent predictors of subclinical TOD (all P < 0.05). ROC analysis showed nighttime SBP SD had an AUC of 0.837 (95% CI: 0.773–0.901), cutoff 12.25 mmHg, sensitivity 89.4%, specificity 78.0%, outperforming other indices (all P < 0.05). Subgroup analyses confirmed nighttime SBP SD independently predicted cardiac, vascular, and renal TOD, while 24-h SBP ARV predicted cardiac and vascular injury (all P < 0.05). Conclusion Nighttime SBP variability (SD) from ABPM independently predicts subclinical TOD and guides organ protection in hypertension.
M Masked and particularly isolated nocturnal hypertension were highly prevalent, underscoring the importance of ABPM in this population, and PWV abnormalities were observed in children with ambulatory hypertension, suggesting that PWV changes are more closely related to blood pressure abnormalities than to the diagnosi...
ABPM improves the diagnostic classification of hypertension and reveals a high prevalence of discordant phenotypes and nocturnal blood pressure abnormalities, and wider use of ABPM may help optimize patient management in this setting.
N. Gaye, J. Mingou, Coumba Kaba et al.· Cardiology and Cardiovascula...· 0 citations
In this community-based cohort of older adults, HBPM provided stable BP estimates within three days (can be non-consecutive within an 8-day period) using morning and evening sessions with ≥2 readings each, supporting shorter, less burdensome HBPM protocols in clinical guidelines for hypertension management in older adu...
Frances M Wang, Hannah V Col, F. L. Kwapong et al.· American Journal of Hyperten...· 0 citations
In young individuals asymptomatic HMOD is associated with both nocturnal hypertension and non-dipping, however, nighttime BP levels seem to have the primary contributing role.
Aikaterini G. Theodosiadi, A. Kollias, E. Stambolliu et al.· Journal of Hypertension· 0 citations
This represents the first evaluation of a Device Type 3 cuffless blood pressure algorithm (automated, wearable, demographic-calibrated, not at heart level) meeting ESH awake/asleep test criteria, suggesting Alysis-001's potential as a clinically viable alternative for ambulatory blood pressure monitoring in hypertensiv...
K. Hongyo, Atsushi Hirayama, Kosuke Shimizu et al.· Hypertension Research· 0 citations
Intensifying pharmacological treatment in sub-Saharan Africa, including antihypertensives, lipid-lowering agents, antidiabetic medications, and aspirin, should create an opportunity for improved overall cardiovascular and metabolic prevention.
Dong-Yan Zhang, De-Wei An, Yu-Ling Yu et al.· Journal of Hypertension· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.